FALLS CHURCH, Va., May 8, 2019 /PRNewswire-PRWeb/ -- The FDA in a Post-Gottlieb World Gottlieb's Accomplishments, New Policies — and a Look Ahead An FDAnews Webinar Wednesday, May 22, 2019, 1:30 p.m. - 3:00 p.m. EDT
https://www.fdanews.com/postgottliebworld
Join us to learn whether the changes and reforms Dr. Scott Gottlieb made during his two years as FDA Commissioner will affect product development and approval applications.
Wayne Pines — Consultant and former associate commissioner of the FDA — Kevin Madagan — Partner, Reed Smith, LLP — and Kalah Auchincloss —Senior Vice President, Regulatory Compliance and Deputy General Counsel, Greenleaf Health — will address these issues and discuss what the future might hold for the FDA in terms of how and whether Gottlieb's initiatives will be carried out and how the FDA will function through the remainder of 2019 and beyond.
In our upcoming webinar attendees will discover the effect of Dr. Gottlieb's departure on:
Interested in registering multiple sites? Call (888) 838-5578 in the U.S. or +1 (703) 538-7600 globally to learn about our special multisite discount.
Webinar Details: The FDA in a Post-Gottlieb World Gottlieb's Accomplishments, New Policies — and a Look Ahead An FDAnews Webinar Wednesday, May 22, 2019, 1:30 p.m. - 3:00 p.m. EDT https://www.fdanews.com/postgottliebworld
Tuition: $287 per site
Easy Ways to Register: Online: https://www.fdanews.com/postgottliebworld By phone: 888-838-5578 or 703-538-7600
About FDAnews: FDAnews is the premier provider of domestic and international regulatory, legislative, and business news and information for executives in industries regulated by the US FDA and the European Medicines Agency. Pharmaceutical and medical device professionals rely on FDAnews' print and electronic newsletters, books and conferences to stay in compliance with international standards and the FDA's complex and ever-changing regulations.
SOURCE FDANEWS
Advertisement
Join us to learn whether the changes and reforms Dr. Scott Gottlieb made during his two years as FDA Commissioner will affect product development and approval applications.
Advertisement
Wayne Pines — Consultant and former associate commissioner of the FDA — Kevin Madagan — Partner, Reed Smith, LLP — and Kalah Auchincloss —Senior Vice President, Regulatory Compliance and Deputy General Counsel, Greenleaf Health — will address these issues and discuss what the future might hold for the FDA in terms of how and whether Gottlieb's initiatives will be carried out and how the FDA will function through the remainder of 2019 and beyond.
In our upcoming webinar attendees will discover the effect of Dr. Gottlieb's departure on:
- Policy decisions on generic drug approvals
- Reorganization of the Office of New Drugs
- Changes in orphan drug policy
- New initiatives dealing with the effort to reduce drug prices
- Further changes in FDA's policies on advertising and promotion regulation
- Changes in FDA standards for clinical trials
Interested in registering multiple sites? Call (888) 838-5578 in the U.S. or +1 (703) 538-7600 globally to learn about our special multisite discount.
Webinar Details: The FDA in a Post-Gottlieb World Gottlieb's Accomplishments, New Policies — and a Look Ahead An FDAnews Webinar Wednesday, May 22, 2019, 1:30 p.m. - 3:00 p.m. EDT https://www.fdanews.com/postgottliebworld
Tuition: $287 per site
Easy Ways to Register: Online: https://www.fdanews.com/postgottliebworld By phone: 888-838-5578 or 703-538-7600
About FDAnews: FDAnews is the premier provider of domestic and international regulatory, legislative, and business news and information for executives in industries regulated by the US FDA and the European Medicines Agency. Pharmaceutical and medical device professionals rely on FDAnews' print and electronic newsletters, books and conferences to stay in compliance with international standards and the FDA's complex and ever-changing regulations.
SOURCE FDANEWS
